Wenhan Li

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Serotonin transporter acts as a tumor suppressor in cervical cancer.

Serotonin transporter acts as a tumor suppressor in cervical cancer.

Journal: Cellular signalling

Published: March 09, 2026

Ovarian cancer-derived ADAMTS2 promotes the omental pre-metastatic niche formation through remodeling collagen I.

Ovarian cancer-derived ADAMTS2 promotes the omental pre-metastatic niche formation through remodeling collagen I.

Journal: Biology direct

Published: February 17, 2026

Correction: Combined CHK1 and PD-L1 blockade as a novel therapeutic strategy against stemness and immunosuppression in ovarian cancer.

Correction: Combined CHK1 and PD-L1 blockade as a novel therapeutic strategy against stemness and immunosuppression in ovarian cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: February 12, 2026

Development and internal validation of a nomogram for identifying intrinsic capacity impairment among community-dwelling older adults in China: a cross-sectional study.

Development and internal validation of a nomogram for identifying intrinsic capacity impairment among community-dwelling older adults in China: a cross-sectional study.

Journal: BMC geriatrics

Published: January 09, 2026

Sarcopenia and cognitive impairment: a multidimensional study of clinical associations, shared genetics, and causal links.

Sarcopenia and cognitive impairment: a multidimensional study of clinical associations, shared genetics, and causal links.

Journal: Frontiers in aging neuroscience

Published: September 18, 2025

Liquid-liquid phase separation of CBX2 regulates lipid raft-mediated extracellular vesicle biogenesis to facilitate ovarian carcinoma metastasis.

Liquid-liquid phase separation of CBX2 regulates lipid raft-mediated extracellular vesicle biogenesis to facilitate ovarian carcinoma metastasis.

Journal: NPJ precision oncology

Published: August 29, 2025

Combined CHK1 and PD-L1 blockade as a novel therapeutic strategy against stemness and immunosuppression in ovarian cancer.

Combined CHK1 and PD-L1 blockade as a novel therapeutic strategy against stemness and immunosuppression in ovarian cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: July 12, 2025

Efferocytosis-Driven Polyamine Metabolism in Macrophages Enhances Cancer Stem Cell Enrichment after Chemotherapy in Ovarian Cancer.

Efferocytosis-Driven Polyamine Metabolism in Macrophages Enhances Cancer Stem Cell Enrichment after Chemotherapy in Ovarian Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 05, 2025

Risk assessment in a Chinese cohort of 96 318 females undergoing opportunistic cervical cancer screening.

Risk assessment in a Chinese cohort of 96 318 females undergoing opportunistic cervical cancer screening.

Journal: The oncologist

Published: April 17, 2025

Extracellular vesicles from ovarian cancer cells induce senescent lipid-laden macrophages to facilitate omental metastasis.

Extracellular vesicles from ovarian cancer cells induce senescent lipid-laden macrophages to facilitate omental metastasis.

Journal: Journal of nanobiotechnology

Published: March 28, 2025

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness.

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: March 11, 2025

LEF1 confers resistance to DNA-damaging chemotherapies through upregulation of PARP1 and NUMA1 in ovarian cancer.

LEF1 confers resistance to DNA-damaging chemotherapies through upregulation of PARP1 and NUMA1 in ovarian cancer.

Journal: Oncogene

Published: December 30, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026